This could inform therapeutic strategies for combining adoptive NK cell transfer and IL-15 administration with targeting of STAT3 in cancer and attenuating the known interference of STAT3 inhibition with NK cell anti-tumor activity51,52. The gene discussed is STAT3; the disease is neoplasm.